PSS10 Cost- Effectiveness of Ranibizumab in Patients With Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.1354